Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands,
Int J Clin Pharm. 2014 Jun;36(3):630-5. doi: 10.1007/s11096-014-9947-4. Epub 2014 Apr 16.
Research on the benefits of clinical medication reviews (CMRs) performed by pharmacists has been conducted mostly in controlled settings and has been widely published. Less is known of the effects after large scale implementation in community pharmacies. An online CMR tool enabled the systematic registration of drug-related problems (DRPs) and implemented interventions derived from CMRs in daily practice.
To describe the effects of CMRs on pharmacy practice after large-scale implementation in the Netherlands.
268 community pharmacies. Pharmacists were trained on CMRs with a patient centred approach.
Retrospective analyses of DRPs, pharmacists' proposals and implemented interventions recorded between January 1st and September 1st 2012.
Frequencies of DRPs, intervention proposals, implemented interventions, and drugs involved.
4,579 CMRs were analysed. On average 2.9 (SD 2.1) DRPs per review were identified. 4,123 (31 %) of the DRPs led to medication changes. Stopping a drug (16 %) was more frequent than starting a drug (8.1 %). Drugs related to cardiovascular risk management, diabetes and osteoporosis were most frequently involved.
This study is the largest analysis of pharmacists-initiated CMRs in the Netherlands to date. The findings demonstrate the potential to reduce medication-related errors through pharmacist involvements in complex pharmacotherapy and the positive impact on the quality of drug therapy through making necessary medication changes. The data also support the need for large-scale implementation of pharmacists-initiated CMRs in the presence of proper training programmes.
对药剂师进行的临床药物审查(CMR)的益处的研究主要在对照环境中进行,并得到了广泛的发表。在社区药房中大规模实施后的效果则知之甚少。一种在线 CMR 工具使药物相关问题(DRP)的系统登记以及从 CMR 中得出的干预措施在日常实践中得以实施成为可能。
描述在荷兰大规模实施后 CMR 对药房实践的影响。
268 家社区药房。药剂师接受了以患者为中心的 CMR 培训。
对 2012 年 1 月 1 日至 9 月 1 日期间记录的 DRP、药剂师建议和实施的干预措施进行回顾性分析。
DRP、干预建议、实施的干预措施和涉及的药物的频率。
共分析了 4579 次 CMR。平均每次审查发现 2.9(SD 2.1)个 DRP。4123 个(31%)DRP 导致药物改变。停止药物(16%)比开始药物(8.1%)更频繁。与心血管风险管理、糖尿病和骨质疏松症相关的药物最常涉及。
这是迄今为止荷兰最大规模的药剂师发起的 CMR 分析。研究结果表明,药剂师参与复杂的药物治疗可以减少与药物相关的错误,并通过进行必要的药物改变对药物治疗质量产生积极影响。数据还支持在适当的培训计划的情况下,在大规模实施药剂师发起的 CMR 的必要性。